Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy.

Pilotti, V

Transfer factor as an adjuvant to non-small cell lung cancer (NSCLC) therapy. [electronic resource] - Biotherapy (Dordrecht, Netherlands) 1996 - 117-21 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0921-299X

10.1007/BF02628668 doi


Adjuvants, Immunologic--adverse effects
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung--pathology
Combined Modality Therapy
Female
Humans
Immunotherapy
Longitudinal Studies
Lung Neoplasms--pathology
Male
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Transfer Factor--adverse effects